Synaffix and Mitsubishi Tanabe Pharma ink license agreement for ADC technology
Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement
Usage of Synaffix GlycoConnect, HydraSpace and toxSYN ADC technologies to enhance efficacy, tolerability and target engagement
QUANTI clinical development program evaluated the efficacy and safety of the investigational MRI contrast agent gadoquatrane for a broad range of potential indications and in pediatric and adult patients
The transaction is part of a broader agreement with Bureau Veritas covering its worldwide food laboratory testing activities
This strategic move aims to address the increasing global demand for biologics, enhancing ProBioGen's ability to support partners from cell line development t
The project is set to attract significant manufacturing investments of approximately Rs. 10,500 crore and is also projected to create around 1 lakh direct and indirect jobs
He also laid the foundation stone for a state-of-the-art 50-bedded Critical Care Block (CCB)
Acquisition expands high-value medical platform
Lilly plans to hire approximately more than 1,000 new highly-skilled team members
Data from IDSP does not indicate any unusual rise in ILI/SARI cases anywhere in the country
These initiatives will strengthen the company’s capital base, providing financial flexibility for future
Subscribe To Our Newsletter & Stay Updated